Fox Chase Cancer Center
The Fox Chase Cancer Center is a comprehensive cancer center for research, physician training and patient care. The Center was formed in 1974 with the merger of the first cancer hospital, American Oncologic Hospital and the Institute for Cancer Research. Today, Fox Chase Cancer Center located in the Philadelphia, Pennsylvania metro area is a leading research, patient treatment and physician training center. Research takes place in more than 80 labs within the Center and employs more than 325 physicians and scientists.
Address
333 Cottman Avenue
Philadelphia, PA 19111-2497
Wikipedia link
News Office
Lisa [dot] Bailey [at] fccc [dot] edu
Phone
215-214-3954
Fax
Contact
"Fox Chase Cancer Center" in the news:
Educational initiatives improve quality of care delivery
May 15, 2009 |
not rated yet |
0
A study of targeted educational initiatives between the clinical staff at Fox Chase Cancer Center and the hospitals within their Partners program suggest that educational interventions by academic cancer centers can improve ...
Study finds it's safe to treat HER2-positive breast cancer with trastuzumab and adjuvant radiation
Nov 03, 2009 |
not rated yet |
0
Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab (Herceptin)--typically used in combination with chemotherapy. However, a new study by researchers ...
Undetectable PSA after radiation is possible and predicts good patient outcomes
Nov 02, 2009 |
not rated yet |
0
Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients. Patients who have an undetectable level of PSA ...
Study finds that lung cancer patients respond to erlotinib following cetuximab therapy
Aug 02, 2009 |
5 / 5 (1) |
0
Non-small cell lung cancer patients who have progressed on a cetuximab-containing regimen may respond to erlotinib, Fox Chase Cancer Center researchers reported today at the annual meeting of the International Association ...
Robotic approach to urothelial cancer of the kidney proves to be beneficial for patients
Apr 26, 2009 |
not rated yet |
0
Robotic trained surgeons at Fox Chase Cancer Center in Philadelphia presented a new and novel approach to surgically treat urothelial cancer (in the lining of the bladder or kidney) today at the American Urological Association's ...
Pregnancy hormone hCG protects against breast cancer even in short-term treatments
Apr 20, 2009 |
not rated yet |
0
One of the most effective ways to prevent breast cancer is through a full-term pregnancy at an early age. Studies out of Fox Chase Cancer Center have linked this protective effect to the presence of human chorionic gonadotropin ...
Cancer survivors may not be getting the help they need to stop smoking
Oct 20, 2009 |
not rated yet |
0
More than a quarter of cancer survivors who still smoke have not been advised to quit smoking by their health care providers in the last year, according to a study published by researchers at Fox Chase Cancer Center in the ...
Does the distance a patient has to travel affect where they choose to get their care?
Aug 31, 2009 |
not rated yet |
0
Do patients choose where to get their care based on how long it takes to them to get there? Researchers at Fox Chase Cancer Center have recently documented a growing trend in the centralization of cancer surgery—more patients ...
Genetic marker may predict early onset of prostate cancer
May 15, 2009 |
5 / 5 (1) |
0
Fox Chase Cancer Center researchers have identified a genetic marker that is associated with an earlier onset of prostate cancer in Caucasian men who have a family history of prostate cancer. If the data are confirmed, the ...
Predicting patient response to gleevec in gastrointestinal stromal tumors
Apr 21, 2009 |
not rated yet |
0
Researchers at Fox Chase Cancer Center uncovered a genetic pattern that may help predict how gastrointestinal stromal tumor (GIST) patients respond to the targeted therapy imatinib mesylate (Gleevec). Moreover, their findings ...
Antibody gives cancer the recognition it deserves
Apr 22, 2009 |
5 / 5 (1) |
0
In concept, the human immune system has the power to destroy cancer cells with great specificity. Therefore, cancer vaccines, like vaccines against influenza or other diseases, offer the hope of enticing the immune system ...
Differences identified in treatments of of patients with second primary lung cancers versus primary lung cancer
Aug 02, 2009 |
not rated yet |
1
Patients with second primary lung cancers (SPLC), when compared to those with one primary lung cancer (OPLC), are more likely to have localized disease at the time of diagnosis and are more likely to receive surgical treatment ...
Regular physical activity linked to better quality of life in early-stage lung cancer survivors
Feb 03, 2009 |
not rated yet |
0
Survivors of early-stage lung cancer who take part in regular physical activity have a better quality of life, according to a study in the February issue of the journal Cancer Epidemiology Biomarkers and Prevention, available ...
Smoking does not lead to more aggressive or advanced breast cancers
Oct 28, 2007 |
not rated yet |
0
Smoking cigarettes is associated with an increased risk of cancers of the lung, head and neck, esophagus, bladder and many others and also affects response to anti-cancer treatments. But smoking does not result in more advanced ...
Enzyme inhibitor takes an unexpected approach toward blocking cancer-promoting protein
Sep 08, 2009 |
not rated yet |
0
Scientists at Fox Chase Cancer Center have discovered a unique method of attack that may be used to inhibit signaling enzymes called kinases, which often have a role in sustaining drug-resistant cancerous cells. They have ...
